U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H13N3O
Molecular Weight 287.316
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RUTECARPINE

SMILES

c1ccc2c(c1)c3CCn4c(-c3[nH]2)nc5ccccc5c4=O

InChI

InChIKey=ACVGWSKVRYFWRP-UHFFFAOYSA-N
InChI=1S/C18H13N3O/c22-18-13-6-2-4-8-15(13)20-17-16-12(9-10-21(17)18)11-5-1-3-7-14(11)19-16/h1-8,19H,9-10H2

HIDE SMILES / InChI

Molecular Formula C18H13N3O
Molecular Weight 287.316
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment:: https://www.ncbi.nlm.nih.gov/pubmed/21423291

Rutaecarpine is an indolopyridoquinazolinone alkaloid isolated from Evodia rutaecarpa and related herbs, first isolated by Asahina and Kashiwaki. Among the active components of evodia are quinolone and indoloquinazoline alkaloids, such as evodiamine and rutaecarpine. A significant portion of the analgesic effects of evodia is attributed to these alkaloids. Rutaecarpine has also been shown to have anti-inflammatory action that is related to inhibition of COX-2, as well as other mechanisms. Evodia rutaecarpa ('Wu-Chu-Yu') remains the most popular and multi-purpose herb traditionally used in China for treatment of headache, abdominal pain, postpartum hemorrhage, dysentery and amenorrhea. Rutaecarpine is one of the main active component isolated from 'Wu-Chu-Yu'. Rutaecarpine has been shown to have cardiovascular biological effects such as inotropic and chronotropic, vasorelaxant, anti-platelet aggregation and anti-inflammatory effects. Furthermore, rutaecarpine has the potential for use as an anti-atherosclerosis agent with a novel mechanism. Rutaecarpine prevents hypoxia-reoxygenation-induced myocardial cell apoptosis via inhibition of NADPH oxidases. Also was shown, that rutaecarpine could be effective in preventing the growth of a variety of cancer cells, including downregulating the estrogen receptor of breast cancer.

Approval Year

PubMed

PubMed

TitleDatePubMed
Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion.
2005 Apr 29
Physicochemical characterization of rutaecarpine-loaded microemulsion system.
2005 Aug
Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
2005 Feb
Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats.
2005 Jul
Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine.
2005 Mar
The protective effects of rutaecarpine on gastric mucosa injury in rats.
2005 May
Identification of the microsomal oxidation metabolites of rutaecarpine, a main active alkaloid of the medicinal herb Evodia rutaecarpa.
2005 May 27
Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms.
2006 Apr
Characterization of human liver cytochrome P450 enzymes involved in the metabolism of rutaecarpine.
2006 Apr 11
Determination of evodiamine and rutecarpine in human serum by liquid chromatography-tandem mass spectrometry.
2006 Jul
Development and validation of HPLC methods for the analysis of phenethylamine and indoloquinazoline alkaloids in Evodia species.
2006 Mar
Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
2006 May
Elimination of rutaecarpine and its metabolites in rat feces and urine measured by liquid chromatography.
2006 Nov
Chemical and biological comparisons on Evodia with two related species of different locations and conditions.
2006 Nov 24
The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats.
2007 Dec
Calcitonin gene-related Peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats.
2007 Dec
In vitro and in vivo antiallergic effect of the fructus of Evodia rutaecarpa and its constituents.
2007 Jan
Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells.
2007 Jan 26
Radical reactions with 3H-quinazolin-4-ones: synthesis of deoxyvasicinone, mackinazolinone, luotonin A, rutaecarpine and tryptanthrin.
2007 Jan 7
[Methodological studies on equivalent relationship between granule for clinical prescription and clinical decoction of fructus evodiae].
2007 Jun
Short communication: in vivo evaluation of microemulsion system for oral and parenteral delivery of rutaecarpine to rats.
2007 May
One-pot synthesis of simple alkaloids: 2,3-polymethylene-4(3H)-quinazolinones, luotonin A, tryptanthrin, and rutaecarpine.
2008 Apr
Rutaecarpine induces chloride secretion across rat isolated distal colon.
2008 Apr
Solid dispersion of rutaecarpine improved its antihypertensive effect in spontaneously hypertensive rats.
2008 Dec
Quality evaluation of Evodia rutaecarpa (Juss.) Benth by high performance liquid chromatography with photodiode-array detection.
2008 Dec 1
Molecular authentication and quality control using a high performance liquid chromatography technique of Fructus Evodiae.
2008 Feb
Progress in the studies on rutaecarpine.
2008 Feb 6
Reduction of asymmetric dimethylarginine in the protective effects of rutaecarpine on gastric mucosal injury.
2008 Oct
Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats.
2008 Oct
Induction of NAD(P)H: quinone reductase by rutaecarpine isolated from the fruits of Evodia rutaecarpa in the murine hepatic Hepa-1c1c7 cell line.
2008 Sep
A flexible synthesis of 2,3-disubstituted indoles from aminobenzyl phosphonium salts. A direct synthesis of rutaecarpine.
2009 Aug 7
Up-regulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium.
2009 Dec 21
The permeability and the efflux of alkaloids of the Evodiae fructus in the Caco-2 model.
2009 Jan
Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation.
2009 May 1
Isolation of secondary metabolites from Hortia oreadica (Rutaceae) leaves through high-speed counter-current chromatography.
2009 May 8
[Determination of evodiamine and rutaecarpine of compound Wuzhuyu cataplasm in plasma by SPE-HPLC: application to its pharmacokinetics].
2009 Nov
[Assay of evodin, evodiamine and rutaecarpine in Fructus Evodiae by QAMS].
2009 Nov
Rutecarpine ameliorates bodyweight gain through the inhibition of orexigenic neuropeptides NPY and AgRP in mice.
2009 Nov 20
Synthesis and biological properties of benzo-annulated rutaecarpines.
2010
Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors.
2010 Apr
Regulation of dioxin receptor function by different beta-carboline alkaloids.
2010 Aug
Anti-proliferative effects of evodiamine on human thyroid cancer cell line ARO.
2010 Aug 15
Optimization of extraction of evodiamine and rutaecarpine from fruit of Evodia rutaecarpa using modified supercritical CO(2).
2010 Dec 10
A new quinolone and other constituents from the fruits of Tetradium ruticarpum: effects on neutrophil pro-inflammatory responses.
2010 Jul
Pharmacological effects of rutaecarpine as a cardiovascular protective agent.
2010 Mar 15
Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide.
2010 May
Reversal of isoprenaline-induced cardiac remodeling by rutaecarpine via stimulation of calcitonin gene-related peptide production.
2010 Oct
Investigation on fragmentation pathways of rutaecarpine and its two derivatives using electrospray ionization ion-trap time-of-flight tandem mass spectrometry.
2010 Sep
Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages.
2013 Mar 7
A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression.
2015 May

Sample Use Guides

The appropriate dose of evodia depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for evodia. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
Route of Administration: Oral
Rutaecarpine was reported to inhibited monocyte migration, which indicates its potential for anti-atherosclerosis activity. There were evaluzted the effect of rutaecarpine on endothelial dysfunction, and focused on the regulation of connexin expression in endothelial cells by rutaecarpine. Endothelia damage was induced by exposing HUVEC-12 to Ox-LDL (100 mg/L) for 24h, which decreased the expression of protective proteins Cx37 and Cx40, but induced atherogenic Cx43 expression, in both mRNA and protein levels, concomitant with the impaired propidium iodide diffusion through the gap junctions. Pretreatment with rutaecarpine effectively recovered the expression of Cx37 and Cx40, but inhibited Cx43 expression, thereby improving gap junction communication and significantly prevented the endothelial dysfunction
Substance Class Chemical
Created
by admin
on Sat Jun 26 16:37:54 UTC 2021
Edited
by admin
on Sat Jun 26 16:37:54 UTC 2021
Record UNII
8XZV289PRY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RUTECARPINE
MI  
Common Name English
8,13-DIHYDROINDOLO(2',3':3,4)PYRIDO(2,1-B)QUINAZOLIN-5(7H)-ONE
Systematic Name English
RUTAECARPINE
Common Name English
RUTECARPINE [MI]
Common Name English
NSC-258317
Code English
Classification Tree Code System Code
DSLD 1394 (Number of products:104)
Created by admin on Sat Jun 26 16:37:54 UTC 2021 , Edited by admin on Sat Jun 26 16:37:54 UTC 2021
Code System Code Type Description
MESH
C028632
Created by admin on Sat Jun 26 16:37:54 UTC 2021 , Edited by admin on Sat Jun 26 16:37:54 UTC 2021
PRIMARY
PUBCHEM
65752
Created by admin on Sat Jun 26 16:37:54 UTC 2021 , Edited by admin on Sat Jun 26 16:37:54 UTC 2021
PRIMARY
EPA CompTox
84-26-4
Created by admin on Sat Jun 26 16:37:54 UTC 2021 , Edited by admin on Sat Jun 26 16:37:54 UTC 2021
PRIMARY
CAS
84-26-4
Created by admin on Sat Jun 26 16:37:54 UTC 2021 , Edited by admin on Sat Jun 26 16:37:54 UTC 2021
PRIMARY
MERCK INDEX
M9702
Created by admin on Sat Jun 26 16:37:54 UTC 2021 , Edited by admin on Sat Jun 26 16:37:54 UTC 2021
PRIMARY Merck Index
FDA UNII
8XZV289PRY
Created by admin on Sat Jun 26 16:37:54 UTC 2021 , Edited by admin on Sat Jun 26 16:37:54 UTC 2021
PRIMARY